Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2026

Earnings Per Share [Abstract]

Schedule of antidilutive securities excluded from computation of earnings per share

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive (in common stock equivalent shares):

	As of September 30,
	2026		2025
Outstanding stock options		2,848,293		2,179,167
Unvested early exercised stock options		124,823		90,021
Series A-1 Convertible Preferred Stock		1,293,694		1,293,694
Series A-2 Convertible Preferred Stock		1,992,290		1,992,290
Series A-3 Convertible Preferred Stock		3,229,832		3,229,832
Series B Convertible Preferred Stock		11,226,401		7,039,280
Total		20,715,333		15,824,284